Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2005
10/19/2005EP1585806A2 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
10/19/2005EP1585549A2 Improved gastrin releasing peptide compounds
10/19/2005EP1585537A1 1-desamino-8-d-arginyl vasopressin analogs
10/19/2005EP1438333A4 Anti-fusion assay
10/19/2005CN1685064A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/19/2005CN1685056A Production method for iturin A and its homologues
10/19/2005CN1684973A Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
10/19/2005CN1684972A Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy
10/19/2005CN1684703A Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
10/19/2005CN1683395A Nuclear factor-K B P65 subunit antagonistic peptide and its use
10/19/2005CN1683394A Biological fermenting producing process for blood vessel cell adhesive receptor luring oligopeptide and use
10/19/2005CN1683393A Process for preparing blood vessel cell adhesive protein receptor luring oligo peptide and use
10/19/2005CN1683392A Chinese hard tick neuropeptide and its preparing method and use
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/19/2005CN1223603C Bioactive peptide No.26
10/19/2005CN1223602C Bioactive peptide No.11
10/18/2005US6955915 Solid phase synthesis; photolithography
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955891 Reagents for assaying Bacillus anthracis lethal factor protease
10/13/2005WO2005095962A1 Method for immobilizing polypeptides and solid supports having polypeptides immobilized thereon
10/13/2005WO2005095593A1 Method for modification of nmda receptors through inhibition of src
10/13/2005WO2005095445A1 Novel basic antibacterial peptide and utilization thereof
10/13/2005WO2005095444A2 Synthetic peptides containing the motif ‘ywwlxp’ as anthrax toxin antidotes
10/13/2005WO2005095443A1 Drug delivery system using peptide modification
10/13/2005WO2005095442A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/13/2005WO2005095441A1 Epithelial cell growth promoter
10/13/2005WO2005095331A1 Agent for binding sugar chain to peptide
10/13/2005WO2005094870A2 Use of osteopontin fragment svvglr-derived peptides for the treatment of ischemic diseases
10/13/2005WO2005094865A1 Compound having angiogenic effect
10/13/2005WO2005067648A3 Multiplex spatial profiling of gene expression
10/13/2005WO2005056581A3 Peptide able to specifically bind a chemokine receptor and use thereof
10/13/2005WO2005056577A3 Peptide inhibitors of hiv
10/13/2005US20050227924 Peyer's patch and/or M-cell targeting ligands
10/13/2005US20050227914 hydrolysis of methyl 4-[5-(4-pentyloxyphenyl)isoxazol-3-yl]benzoate with potassium hydroxide, then reacting the potassium salt with hydrochloric acid, to form 4-[5-(4-pentyloxyphenyl)isoxazol-3-yl]benzoic acid, used as intermediates for peptide antibiotics; echinocandin derivatives
10/13/2005US20050227314 selectively splitting the polypeptide at a Cys-His site, by hydrolysis in presence of a palladium promotor dissolved in formic acid; purification with by-product inhibition
10/13/2005US20050227313 Polypeptide cleavage process
10/13/2005US20050226891 Multiple antigenic peptides immunogenic against Streptococcus pneumonia
10/13/2005US20050226881 Isolated peptide which binds to HLA-Cw*07 and uses thereof
10/13/2005US20050226821 Cosmetic formulations containing l-arginine oligomers
10/13/2005CA2847454A1 Method for modification of nmda receptors through inhibition of src
10/13/2005CA2561376A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/13/2005CA2560906A1 Method for modification of nmda receptors through inhibition of src
10/12/2005EP1584627A1 Dimerized peptide
10/12/2005EP1584625A1 Method of preparing tripeptide intermediates for the preparation of LHRH antagonists
10/12/2005EP1583774A2 Methods for preventing and treating alzheimer's disease (ad)
10/12/2005EP1583587A2 Organic compounds with biological action as thrombin inhibitors and use therof
10/12/2005EP1583564A2 Improved linkers for pharmaceutical compounds
10/12/2005EP1583562A2 Aprotinin and analogs as carriers across the blood-brain barrier
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1511765A4 Par-2-activating peptide derivative and pharmaceutical composition using the same
10/12/2005EP1468012A4 Biomolecule transduction motif mph-1-btm and the use thereof
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005CN1681845A Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
10/12/2005CN1680566A Pseudomycin production by pseudomonas syringae
10/12/2005CN1680430A Mimic peptide of human plasminogen activator and preparation thereof
10/12/2005CN1680429A Anti-oxidation peptide from bee milk
10/12/2005CN1680402A Water soluble prodrugs of hindered alcohols
10/12/2005CN1679915A Peptide antagonists of zonulin and methods for use of the same
10/12/2005CN1222537C Preparing process for Eptifibatide
10/11/2005USRE38828 Parevins and tachytegrins
10/11/2005US6953780 Endothelin antagonist
10/11/2005US6953779 Administering oligopeptide
10/11/2005US6953567 Radiolabeling peptides by reacting thiol-containing peptides with an F-18-bound labelling reagent which also has a group that is reactive with thiols; targeted to a tissue using bispecific antibodies
10/11/2005CA2333875C Redox reversible bipyridyl osmium complex conjugates
10/11/2005CA2333732C Redox reversible imidazole-osmium complex conjugates
10/06/2005WO2005093075A1 Peptide-based method for monitoring gene expression in a host cell
10/06/2005WO2005093069A2 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
10/06/2005WO2005093068A1 Novel protein and promoter
10/06/2005WO2005092916A1 Novel fermentation products
10/06/2005WO2005092365A2 Pharmaceutical use of novispirins
10/06/2005WO2004084812A3 Tamandarin analogs and fragments thereof and methods of making and using
10/06/2005WO2004084800A3 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
10/06/2005US20050222390 The peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases
10/06/2005US20050222386 Biomolecule transduction motif sim-2-btm and the use thereof
10/06/2005US20050222384 Useful as prophylactic and therapeutic agent of dysfunction of masticatory, dysphagia, dysgeusia, ozostomia, intra-oral cavity dysphoria, intra-oral cavity infections, intra-oral cavity inflammations, dry eye, ectocornea detachment, keratitis, corneal ulcer, conjunctivitis, stomach and duodenal ulcers
10/06/2005US20050222383 Prostasin substrates and inhibitors
10/06/2005US20050222042 Modifying N-methyl-D-aspartate function without completely blocking the receptor or adversely affecting other neuronal proteins with the use of generalized kinase inhibitors with an oligopeptide that inhibits interaction of the unique domain of the tyrosine kinase Src enzyme and the receptor complex
10/06/2005US20050222041 oligopeptides capable of stimulating neural cell adhesion molecule (NCAM) signalling and/or interfering with cell adhesion, used for treatment of nervous system disorders
10/06/2005US20050222040 Vertebrate peptide modulators of lipid metabolism
10/06/2005US20050222037 Modulates cell adhesion, angiogenesis, maintenance of vascular integrity, regulation of vascular permeability
10/06/2005US20050222035 Peptides and related molecules that modulate nerve growth factor activity
10/06/2005US20050222025 Method of inhibiting fibrosis with a somatostatin agonist
10/06/2005US20050222020 Apoptotically active peptides
10/06/2005US20050222015 Dehydrodidemnin B
10/06/2005US20050222014 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture
10/06/2005US20050222012 Methods and compositions for treating leukemia
10/06/2005US20050222009 Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
10/06/2005US20050221381 Method for isolating ligands
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050220801 Immunopotentiators
10/05/2005EP1581904A2 Novel proteins with altered immunogenicity
10/05/2005EP1581790A2 Peptides that home to tumor lymphatic vasculature and methods of using same
10/05/2005EP1581649A2 Binding agents which inhibit myostatin
10/05/2005EP1581645A2 Method for using division arrested cells in screening assays
10/05/2005EP1581247A1 Methods and compositions for treating polycystic ovary syndrome
10/05/2005EP1001977B1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
10/05/2005CN1678632A A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
1 ... 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 ... 423